Trials / Completed
CompletedNCT02037945
18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to determine the distribution of 18F Fluorocholine (18F-FCH) in the brain which can help distinguishing radiation-induced scarring from tumor regrowth. In addition, the study will measure levels of 18F-FCH in the blood and (if applicable) in the brain lesion tissue that is removed as part of the planned brain surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | 18F-FCH PET Scan |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2022-12-08
- Completion
- 2022-12-08
- First posted
- 2014-01-16
- Last updated
- 2022-12-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02037945. Inclusion in this directory is not an endorsement.